Skip to content

Applied BioSciences Corp.

CIK 0001607549

← back to feed
Revenue (TTM)
$1.04M
+257.9% YoY Q3 Feb 2020
Net Income (TTM)
−$4.68M
−12.2% YoY Q3 Feb 2020
EPS Diluted (TTM)
—
Q3 Feb 2020
Gross Margin
39.4%
Q3 Feb 2020
Operating Margin
-352.2%
Q3 Feb 2020
Net Margin
-450.7%
Q3 Feb 2020
Free Cash Flow (TTM)
−$624.5K
Q3 Feb 2020
Cash
$21.27K
Q3 Feb 2020
Total Debt
—
Q3 Feb 2020
Shares Outstanding
14.29M sh
Q3 Feb 2020

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Recent filings